CAS 2189684-44-2

Lenacapavir

CAS: 2189684-44-2

Formula: C₃₉H₃₂ClF₁₀N₇O₅S₂

Molecular weight: 968.28

Ref: 4Z-L-205001

Lenacapavir

CAS: 2189684-44-2

Lenacapavir

Purity: ≥98%

Molecular weight: 968.28g/mol

Ref: 54-BUP09401

Lenacapavir

CAS: 2189684-44-2

Formula: C₃₉H₃₂ClF₁₀N₇O₅S₂

Color and Shape: Neat

Molecular weight: 968.29

Ref: TR-L329070

Lenacapavir

CAS: 2189684-44-2

Lenacapavir (GS-6207) is the first HIV-1 capsid inhibitor approved by the U.S. Food and Drug Administration, the European Medicines Agency, and Health Canada for the treatment of MDR HIV-1 infection.Cost-effective and quality-assured.

Formula: C₃₉H₃₂ClF₁₀N₇O₅S₂

Purity: 99.61% - 99.87%

Color and Shape: Solid

Molecular weight: 968.28

Ref: TM-T11465

Lenacapavir

CAS: 2189684-44-2

Lenacapavir is a capsid inhibitor with a mode of action that interferes with the HIV capsid protein, disrupting multiple stages of the viral lifecycle. It is used for treating multidrug-resistant HIV infections.

Formula: C₃₉H₃₂ClF₁₀N₇O₅S₂

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 968.28 g/mol

Ref: 3D-AL180739